Rolvedon Alternatives Compared
| Rolvedon (eflapegrastim) | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|---|
| Rolvedon (eflapegrastim) | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy. Rolvedon may also be used for purposes not listed in this medication guide. |
Prescription only
Neulasta injection is a prescription medicine that may be given once every chemotherapy cycle to prevent febrile neutropenia in those people at high risk of it because of cancer treatments they are... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Related suggestions Neutropenia Associated with Chemotherapy
|
|||||||
| More about Rolvedon (eflapegrastim) | More about Neulasta (pegfilgrastim) | More about Neupogen (filgrastim) | ||||||||
| Ratings & Reviews | ||||||||||
|
Rolvedon has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
Neupogen has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Rolvedon side effects |
View all Neulasta side effects |
View all Neupogen side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
View all Rolvedon prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other filgrastim brands include: Nivestym, Nypozi, Releuko, Zarxio | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
36.4 hours |
80 hours |
5.8 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 179 drugs are known to interact with Rolvedon:
|
A total of 179 drugs are known to interact with Neulasta:
|
A total of 176 drugs are known to interact with Neupogen:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| First Approval Date | ||||||||||
|
September 09, 2022 |
January 31, 2002 |
February 20, 1991 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.